NAPRT rs10866912: what the research says
rs10866912
Trait
Moderate evidenceGene: NAPRTA newly reported risk variant associated with schizophrenia that influences niacin metabolism and NAD+ biosynthesis.
Identified in South Indian cohorts, studied for generalizability in European populations.
Our full long-form research profile for rs10866912 — genotype interpretations, evidence review, and FAQ — is being written and will appear on this page soon.
Curious what your genotype is for rs10866912?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29